Over the last 7 days, the Pharma industry has risen 1.7%, and Cipla contributed the most with a gain of 4.5%. Meanwhile, Sanofi India actually underperformed within the industry, shrinking 29% in the last week. This means that the industry has gained 54% over the past year. Earnings are forecast to grow by 17% annually.
Has the Indian Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 16 Jun 2024 | ₹17.7t | ₹3.6t | ₹448.3b | 33x | 39.4x | 5x |
Tue, 14 May 2024 | ₹16.9t | ₹3.5t | ₹428.8b | 33.8x | 39.4x | 4.8x |
Thu, 11 Apr 2024 | ₹17.1t | ₹3.5t | ₹418.9b | 33.5x | 40.9x | 4.9x |
Sat, 09 Mar 2024 | ₹17.1t | ₹3.5t | ₹418.7b | 33.4x | 40.8x | 4.9x |
Mon, 05 Feb 2024 | ₹16.1t | ₹3.4t | ₹408.2b | 35x | 39.5x | 4.7x |
Wed, 03 Jan 2024 | ₹15.4t | ₹3.4t | ₹395.9b | 34.3x | 38.9x | 4.5x |
Fri, 01 Dec 2023 | ₹14.3t | ₹3.4t | ₹395.1b | 31.6x | 36.1x | 4.2x |
Sun, 29 Oct 2023 | ₹12.8t | ₹3.3t | ₹375.3b | 28.8x | 34.2x | 3.9x |
Tue, 26 Sep 2023 | ₹12.9t | ₹3.3t | ₹369.5b | 29.8x | 34.9x | 3.9x |
Thu, 24 Aug 2023 | ₹13.0t | ₹3.3t | ₹367.1b | 29.5x | 35.5x | 4x |
Sat, 22 Jul 2023 | ₹12.2t | ₹3.2t | ₹342.2b | 26.5x | 35.7x | 3.9x |
Mon, 19 Jun 2023 | ₹11.4t | ₹3.2t | ₹342.4b | 27.1x | 33.2x | 3.6x |
Wed, 17 May 2023 | ₹10.4t | ₹3.1t | ₹309.5b | 26.6x | 33.8x | 3.4x |
Fri, 14 Apr 2023 | ₹9.9t | ₹3.0t | ₹277.6b | 25.5x | 35.5x | 3.3x |
Sun, 12 Mar 2023 | ₹9.4t | ₹3.0t | ₹277.5b | 24.4x | 33.7x | 3.1x |
Tue, 07 Feb 2023 | ₹9.7t | ₹3.0t | ₹285.2b | 24.1x | 34x | 3.3x |
Thu, 05 Jan 2023 | ₹9.9t | ₹2.9t | ₹274.9b | 26.7x | 36x | 3.5x |
Sat, 03 Dec 2022 | ₹10.2t | ₹2.9t | ₹274.9b | 26.2x | 37.1x | 3.6x |
Mon, 31 Oct 2022 | ₹10.2t | ₹2.8t | ₹260.6b | 23.7x | 39.1x | 3.6x |
Wed, 28 Sep 2022 | ₹9.6t | ₹2.8t | ₹261.9b | 23.3x | 36.5x | 3.4x |
Fri, 26 Aug 2022 | ₹9.7t | ₹2.8t | ₹261.9b | 22.9x | 37x | 3.5x |
Sun, 24 Jul 2022 | ₹9.6t | ₹2.8t | ₹273.5b | 22.5x | 35.2x | 3.5x |
Tue, 21 Jun 2022 | ₹8.9t | ₹2.8t | ₹273.8b | 19.7x | 32.5x | 3.2x |
Thu, 19 May 2022 | ₹9.5t | ₹2.7t | ₹332.6b | 21.7x | 28.6x | 3.5x |
Sat, 16 Apr 2022 | ₹10.2t | ₹2.7t | ₹338.0b | 24.3x | 30.3x | 3.8x |
Mon, 14 Mar 2022 | ₹9.9t | ₹2.7t | ₹337.9b | 23.4x | 29.4x | 3.7x |
Wed, 09 Feb 2022 | ₹10.1t | ₹2.7t | ₹368.4b | 24.1x | 27.4x | 3.8x |
Fri, 07 Jan 2022 | ₹10.7t | ₹2.7t | ₹360.6b | 36.7x | 29.6x | 4x |
Sun, 05 Dec 2021 | ₹10.1t | ₹2.7t | ₹360.3b | 22.9x | 28x | 3.8x |
Tue, 02 Nov 2021 | ₹10.5t | ₹2.6t | ₹363.9b | 24x | 28.9x | 4x |
Thu, 30 Sep 2021 | ₹10.9t | ₹2.6t | ₹375.7b | 25.8x | 28.9x | 4.2x |
Sat, 28 Aug 2021 | ₹10.7t | ₹2.6t | ₹375.2b | 23.3x | 28.4x | 4.1x |
Sun, 04 Jul 2021 | ₹10.7t | ₹2.6t | ₹371.5b | 24x | 28.9x | 4.2x |
28.9x
Which industries have driven the changes within the Indian Healthcare industry?
IN Market | 2.66% | |
Healthcare | 2.37% | |
Pharma | 1.70% | |
Pharma | 1.70% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
CIPLA Cipla | ₹1.56k | 4.5% +₹54.5b | 55.5% | PE30.7x | |
ZYDUSLIFE Zydus Lifesciences | ₹1.11k | 5.1% +₹54.1b | 101.4% | PE29.1x | |
MANKIND Mankind Pharma | ₹2.24k | 5.3% +₹45.3b | 38.0% | PE46.9x | |
500660 GlaxoSmithKline Pharmaceuticals | ₹2.66k | 6.3% +₹26.9b | 87.7% | PE76.5x | |
NATCOPHARM NATCO Pharma | ₹1.21k | 11.8% +₹23.0b | 92.1% | PE15.6x |